Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
BMC Neuroscience|August 14, 2008
Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic miceMichael A Mastrangelo, William J Bowers
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2007
Neuronal specificity of HSV/sleeping beauty amplicon transduction in utero is driven primarily by tropism and cell type compositionElise B Peterson, Michael A Mastrangelo, Howard J Federoff, et al.
The American Journal of Pathology|October 8, 2009
Interferon-{gamma} differentially affects Alzheimer's disease pathologies and induces neurogenesis in triple transgenic-AD miceMichael A Mastrangelo, Kelly L Sudol, Wade C Narrow, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2003
Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNSJohn A Olschowka, William J Bowers, Sean D Hurley, et al.
Journal of Neuroinflammation|October 20, 2005
Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease miceMichelle C Janelsins, Michael A Mastrangelo, Salvatore Oddo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2010
Abeta-directed single-chain antibody delivery via a serotype-1 AAV vector improves learning behavior and pathology in Alzheimer's disease miceDeborah A Ryan, Michael A Mastrangelo, Wade C Narrow, et al.
The American Journal of Pathology|August 11, 2010
Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic targetMaya K Desai, Michael A Mastrangelo, Deborah A Ryan, et al.
The American Journal of Pathology|April 10, 2013
Chronic neuron- and age-selective down-regulation of TNF receptor expression in triple-transgenic Alzheimer disease mice leads to significant modulation of amyloid- and Tau-related pathologiesSara L Montgomery, Wade C Narrow, Michael A Mastrangelo, et al.
Glia|July 29, 2008
Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathologyMaya K Desai, Kelly L Sudol, Michelle C Janelsins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Reduced Pathology and Improved Behavioral Performance in Alzheimer's Disease Mice Vaccinated With HSV Amplicons Expressing Amyloid-β and Interleukin-4Maria E Frazer, Jennifer E Hughes, Michael A Mastrangelo, et al.
Pageof 3